Versant Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
Versant Capital Management's VCYT Position: Q3 2026 in Review
Versant Capital Management increased its Veracyte (VCYT) stake by 6.9% in Q3 2026, buying an estimated $868 and bringing the position to 279 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2169.
Versant Capital Management first reported a position in VCYT in Q2 2023 and has held it in 12 quarters since. The position peaked at $27.6K in Q1 2025. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- Versant Capital Management held 279 shares of Veracyte worth $12.8K as of Q3 2026.
- Versant Capital Management bought 18 Veracyte shares in Q3 2026, an estimated $868.
- Veracyte made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2169 holding.
- Versant Capital Management first reported a position in Veracyte in Q2 2023 and has held it in 12 quarters since.
- Versant Capital Management's Veracyte position peaked at $27.6K in Q1 2025.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.